首页> 外文期刊>Frontiers in Immunology >Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 bright NKG2A +++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content
【24h】

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56 bright NKG2A +++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

机译:逆变:来自重组酶活化基因患者的自然杀伤细胞和非同源终端连接基因缺陷包括较高频率的CD56 亮相 Nkg2a +++ ++ ++ ++ ++增加脱粒和更高的穿孔素含量

获取原文
           

摘要

There was a mistake in the authorship. The name of Nima Parvaneh was unintentionally omitted. Dr. Parvaneh has contributed biological specimens and clinical and immunological data from patient P66 included in the manuscript, and as such he should be included in the authorship. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.With the inclusion of Dr. Parvaneh’s name in the authorship, the paragraph of Author Contributions should also be corrected as follows:JM, EM, AM, SP, and LN designed the study, interpreted the data, and wrote the manuscript; KD, GT, EC, OP, PM, SG, and DM performed experiments, acquired and analyzed the data; WA-H, CC, MC, JB, CB, DB, SB, TC, JC, VD-C, LOdB, MTdlM, GM, AF, RG, RKG, AH, SH, C-HH, MK, AlKi, BK, AnKl, TK, BL, VL, MiMa, IM, MeMo, BN, S-YP, NP, AP, SP, IR, JS, RS, TT, Y-JK, JW, AG, and SK contributed patient samples and clinical and immunological data; all authors have revised the work for its intellectual content, have approved its final version and have agreed to be accountable for all aspects related to the accuracy and integrity of the work.This correction does not change the scientific conclusions of the article in any way.Author apologizes for these errors and thank you for your consideration.The original has been updated. Conflict of Interest Statement The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
机译:作者中有一个错误。无意中省略了Nima Parvaneh的名称。 Parvaneh博士从稿件中的患者P66贡献了生物标本和临床和免疫数据,因此他应该包含在作者中。作者为错误道歉。此错误不会以任何方式更改文章的科学结论。在作者中包含帕拉涅博士的名称,作者捐款段也应予以纠正如下:JM,EM,AM,SP和LN设计研究,解释了数据,并写了稿件; KD,GT,EC,OP,PM,SG和DM进行了实验,获取和分析了数据; WA-H,CC,MC,JB,CB,DB,SB,TC,JC,VD-C,LODB,MTDLM,GM,AF,RG,RKG,AH,SH,C-HH,MK,ALKI,BK, ANKL,TK,BL,VL,MIMA,IM,MEMO,BN,S-YP,NP,AP,SP,IR,JS,RS,TT,Y-JK,JW,AG和SK贡献患者样品和临床和临床免疫数据;所有作者都修订了其知识分子内容的工作,已批准其最终版本,并已同意对与工作准确性和完整性相关的各个方面负责。此更正不会以任何方式改变文章的科学结论。作者为这些错误道歉,并感谢您的考虑因素。原件已更新。利益冲突声明提交人声明,在没有任何可能被解释为潜在利益冲突的商业或财务关系的情况下进行了研究。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号